Amaia Letona-Zabala
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Publisher Correction: Polyamine-dependent metabolic shielding regulates alternative splicing.
Journal: Nature
Published: January 21, 2026
Correction: The PP2A regulator IER5L supports prostate cancer progression.
Journal: Cell death & disease
Published: July 22, 2025
Loss of UFMylation supports prostate cancer metastasis and rewires cell metabolism towards hexosamine biosynthesis.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Unravelling the role of L- and D- alanine in prostate cancer: a Positron Emission Tomography study in a genetic mouse model.
Journal: Nuclear medicine and biology
Published: March 26, 2025
Transcriptional network analysis of PTEN-protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication.
Journal: Molecular oncology
Published: March 04, 2025
USP29-regulated noncanonical stabilization of the hypoxia-inducible factor-α in aggressive prostate cancer.
Journal: Molecular oncology
Published: November 13, 2024
Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer.
Journal: Cell death & disease
Published: October 08, 2024
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics.
Journal: Cardiovascular diabetology
Published: May 28, 2024
Polyamine-dependent metabolic shielding regulates alternative splicing.
Journal: Nature
Published: January 23, 2024
The PP2A regulator IER5L supports prostate cancer progression.
Journal: Cell death & disease
Published: December 21, 2023
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer.
Journal: Molecular cancer
Published: August 03, 2022
Last Updated: 09/26/2026